Cargando…

Fentanyl Enhances Hepatotoxicity of Paclitaxel via Inhibition of CYP3A4 and ABCB1 Transport Activity in Mice

Fentanyl, a potent opioid analgesic that is used to treat cancer pain, is commonly administered with paclitaxel in advanced tumors. However, the effect of fentanyl on the hepatotoxicity of paclitaxel and its potential mechanism of action is not well studied. The purpose of this study was to investig...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Jing-Dun, Huang, Yang, Chen, Dong-Tai, Pan, Jia-Hao, Bi, Bing-Tian, Feng, Kun-Yao, Huang, Wan, Zeng, Wei-An
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4669130/
https://www.ncbi.nlm.nih.gov/pubmed/26633878
http://dx.doi.org/10.1371/journal.pone.0143701
_version_ 1782404066657173504
author Xie, Jing-Dun
Huang, Yang
Chen, Dong-Tai
Pan, Jia-Hao
Bi, Bing-Tian
Feng, Kun-Yao
Huang, Wan
Zeng, Wei-An
author_facet Xie, Jing-Dun
Huang, Yang
Chen, Dong-Tai
Pan, Jia-Hao
Bi, Bing-Tian
Feng, Kun-Yao
Huang, Wan
Zeng, Wei-An
author_sort Xie, Jing-Dun
collection PubMed
description Fentanyl, a potent opioid analgesic that is used to treat cancer pain, is commonly administered with paclitaxel in advanced tumors. However, the effect of fentanyl on the hepatotoxicity of paclitaxel and its potential mechanism of action is not well studied. The purpose of this study was to investigate the effect of fentanyl on the hepatotoxicity of paclitaxel and its potential mechanisms of action. Pharmacokinetic parameters of paclitaxel were tested using reversed phase high-performance liquid chromatography (RP-HPLC). Aspartate transaminase (AST), alanine aminotransferase (ALT), and mouse liver histopathology were examined. Moreover, the cytotoxicity of anti-carcinogens was examined using 1-(4, 5-dimethylthiazol-2-yl)-3,5-diphenylformazan (MTT), and the intracellular accumulation of doxorubicin and rhodamine 123 was detected by flow cytometry. Furthermore, the expression of ABCB1 and the activity of ABCB1 ATPase and CYP3A4 were also examined. In this study, the co-administration of fentanyl and paclitaxel prolonged the half-life (t(1/2)) of paclitaxel from 1.455 hours to 2.344 hours and decreased the clearance (CL) from 10.997 ml/h to 7.014 ml/h in mice. Fentanyl significantly increased the levels of ALT in mice to 88.2 U/L, which is more than 2-fold higher than the level detected in the control group, and it increased the histological damage in mouse livers. Furthermore, fentanyl enhanced the cytotoxicity of anti-carcinogens that are ABCB1 substrates and increased the accumulation of doxorubicin and rhodamine 123. Additionally, fentanyl stimulated ABCB1 ATPase activity and inhibited CYP3A4 activity in the liver microsomes of mice. Our study indicates that the obvious hepatotoxicity during this co-administration was due to the inhibition of CYP3A4 activity and ABCB1 transport activity. These findings suggested that the accumulation-induced hepatotoxicity of paclitaxel when it is combined with fentanyl should be avoided.
format Online
Article
Text
id pubmed-4669130
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-46691302015-12-10 Fentanyl Enhances Hepatotoxicity of Paclitaxel via Inhibition of CYP3A4 and ABCB1 Transport Activity in Mice Xie, Jing-Dun Huang, Yang Chen, Dong-Tai Pan, Jia-Hao Bi, Bing-Tian Feng, Kun-Yao Huang, Wan Zeng, Wei-An PLoS One Research Article Fentanyl, a potent opioid analgesic that is used to treat cancer pain, is commonly administered with paclitaxel in advanced tumors. However, the effect of fentanyl on the hepatotoxicity of paclitaxel and its potential mechanism of action is not well studied. The purpose of this study was to investigate the effect of fentanyl on the hepatotoxicity of paclitaxel and its potential mechanisms of action. Pharmacokinetic parameters of paclitaxel were tested using reversed phase high-performance liquid chromatography (RP-HPLC). Aspartate transaminase (AST), alanine aminotransferase (ALT), and mouse liver histopathology were examined. Moreover, the cytotoxicity of anti-carcinogens was examined using 1-(4, 5-dimethylthiazol-2-yl)-3,5-diphenylformazan (MTT), and the intracellular accumulation of doxorubicin and rhodamine 123 was detected by flow cytometry. Furthermore, the expression of ABCB1 and the activity of ABCB1 ATPase and CYP3A4 were also examined. In this study, the co-administration of fentanyl and paclitaxel prolonged the half-life (t(1/2)) of paclitaxel from 1.455 hours to 2.344 hours and decreased the clearance (CL) from 10.997 ml/h to 7.014 ml/h in mice. Fentanyl significantly increased the levels of ALT in mice to 88.2 U/L, which is more than 2-fold higher than the level detected in the control group, and it increased the histological damage in mouse livers. Furthermore, fentanyl enhanced the cytotoxicity of anti-carcinogens that are ABCB1 substrates and increased the accumulation of doxorubicin and rhodamine 123. Additionally, fentanyl stimulated ABCB1 ATPase activity and inhibited CYP3A4 activity in the liver microsomes of mice. Our study indicates that the obvious hepatotoxicity during this co-administration was due to the inhibition of CYP3A4 activity and ABCB1 transport activity. These findings suggested that the accumulation-induced hepatotoxicity of paclitaxel when it is combined with fentanyl should be avoided. Public Library of Science 2015-12-03 /pmc/articles/PMC4669130/ /pubmed/26633878 http://dx.doi.org/10.1371/journal.pone.0143701 Text en © 2015 Xie et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Xie, Jing-Dun
Huang, Yang
Chen, Dong-Tai
Pan, Jia-Hao
Bi, Bing-Tian
Feng, Kun-Yao
Huang, Wan
Zeng, Wei-An
Fentanyl Enhances Hepatotoxicity of Paclitaxel via Inhibition of CYP3A4 and ABCB1 Transport Activity in Mice
title Fentanyl Enhances Hepatotoxicity of Paclitaxel via Inhibition of CYP3A4 and ABCB1 Transport Activity in Mice
title_full Fentanyl Enhances Hepatotoxicity of Paclitaxel via Inhibition of CYP3A4 and ABCB1 Transport Activity in Mice
title_fullStr Fentanyl Enhances Hepatotoxicity of Paclitaxel via Inhibition of CYP3A4 and ABCB1 Transport Activity in Mice
title_full_unstemmed Fentanyl Enhances Hepatotoxicity of Paclitaxel via Inhibition of CYP3A4 and ABCB1 Transport Activity in Mice
title_short Fentanyl Enhances Hepatotoxicity of Paclitaxel via Inhibition of CYP3A4 and ABCB1 Transport Activity in Mice
title_sort fentanyl enhances hepatotoxicity of paclitaxel via inhibition of cyp3a4 and abcb1 transport activity in mice
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4669130/
https://www.ncbi.nlm.nih.gov/pubmed/26633878
http://dx.doi.org/10.1371/journal.pone.0143701
work_keys_str_mv AT xiejingdun fentanylenhanceshepatotoxicityofpaclitaxelviainhibitionofcyp3a4andabcb1transportactivityinmice
AT huangyang fentanylenhanceshepatotoxicityofpaclitaxelviainhibitionofcyp3a4andabcb1transportactivityinmice
AT chendongtai fentanylenhanceshepatotoxicityofpaclitaxelviainhibitionofcyp3a4andabcb1transportactivityinmice
AT panjiahao fentanylenhanceshepatotoxicityofpaclitaxelviainhibitionofcyp3a4andabcb1transportactivityinmice
AT bibingtian fentanylenhanceshepatotoxicityofpaclitaxelviainhibitionofcyp3a4andabcb1transportactivityinmice
AT fengkunyao fentanylenhanceshepatotoxicityofpaclitaxelviainhibitionofcyp3a4andabcb1transportactivityinmice
AT huangwan fentanylenhanceshepatotoxicityofpaclitaxelviainhibitionofcyp3a4andabcb1transportactivityinmice
AT zengweian fentanylenhanceshepatotoxicityofpaclitaxelviainhibitionofcyp3a4andabcb1transportactivityinmice